Drug intelligence / Profile preview

Microlyte Matrix

Development stage
Unknown
Lead developer
Imbed Biosciences
Administration
Topical
01

Overview

Microlyte Matrix is a **sterile, single-use absorbent polymeric wound matrix** primarily composed of bioresorbable polyvinyl alcohol with a polymeric surface coating containing low amounts of *ionic and metallic silver* (maximum 0.16 mg/in²)[2][3][9]. Its mechanism of action is to **absorb wound fluid, conform intimately to the wound bed, and create a moist healing environment**. The inclusion of silver serves an **antimicrobial role, limiting microbial growth within the matrix** but without significant systemic absorption. Microlyte Matrix is biocompatible and transparent, providing sustained antimicrobial activity for up to three days, and is effective against a broad range of bacteria and fungi commonly associated with wound infections[2][3][4]. It is indicated for the management of **partial and full thickness wounds** including pressure ulcers, venous stasis ulcers, diabetic ulcers, burns, abrasions, lacerations, donor sites, and surgical wounds. It can also be used over debrided and grafted partial thickness wounds[2][6][7]. Developed and manufactured by Imbed Biosciences, Microlyte Matrix is FDA 510(k) cleared (K153756) and has demonstrated clinical effectiveness in chronic wounds, with studies showing significant wound area reduction and a high proportion of wounds healing or improving significantly by 12 weeks[4][6].

Brand names
Microlyte Matrix
Other names
Microlyte

Beyond the preview

Go deeper on Microlyte Matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microlyte Matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call